← Back

Wire · opportunities

AI Clinical Decision Support Is Outrunning Its Own Evidence Base: What Trial Operators ...

Published

15 August 2026

Topic

opportunities

Sectors

Healthtech Infrastructure

Geography

United States

Source

Read at clinicaltrialvanguard.com

Verified

Fusion42 · 15 August 2026 · Fusion42 review

AI clinical decision support tools are being rapidly adopted in U.S. hospitals and trial sites faster than evidence generation and regulatory frameworks can keep up, causing significant challenges in clinical trial data integrity and regulatory submissions. Sponsors running trials where AI is integrated into clinical workflows face unseen confounders affecting source data verification and monitoring plans.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ The Wire takeaway

Your clinical trial data is already shaped by AI tools your monitoring does not track. Start engaging regulators and sites this week to inventory AI use or risk unforeseeable confounders derailing your trial readouts.

Coverage

1 source · 15 Aug 2026

Related on Wire

Topics

Healthtech Infrastructureai-clinical-supportclinical-trialsdata-integrityregulatory-guidanceehr-integration